ClinicalTrials.Veeva

Menu

Defining Decision Thresholds for Judgments on Health Benefits and Harms: Study Protocol

McMaster University logo

McMaster University

Status

Unknown

Conditions

Decision Support Techniques
GRADE Approach

Treatments

Other: descriptive case-scenarios

Study type

Interventional

Funder types

Other

Identifiers

NCT05237635
GRADETHRESHLD

Details and patient eligibility

About

The objective of this study is an approach to derive and use decision-thresholds for judgments on health benefits and harms using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks.

Full description

The objective of this study is to derive decision-thresholds (DTs) for Evidence to Decision (EtD) judgments on the magnitude of health benefits and harms. The study hypothesis is that DTs could discriminate between the four categories for EtD judgments. Explicit DTs, providing an indication for which could be the appropriate judgment for a given scenario, might have the potential to support panels of decision-makers in their work, facilitate a common understanding, and promote consistency and transparency in judgments.

Study investigators will conduct a methodological randomized controlled trial to collect the data that allow deriving the decision-thresholds. They will invite clinicians, epidemiologists, decision scientists, health research methodologists, experts in Health Technology Assessment (HTA), members of guideline development groups and the public to participate in the trial. Then, investigators will investigate the validity of decision-threshold by measuring the agreement between judgments that were made in the past by guideline panels and the judgments that the DTs approach would suggest if applied on the same guideline data.

Enrollment

1,406 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

The target population of the survey will include:

  • clinicians
  • epidemiologist
  • decision scientists
  • health research methodologists
  • experts in health technology assessment (HTA)
  • and members of guideline working groups
  • members from the general public

Exclusion criteria

• Prior participation in the survey

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Triple Blind

1,406 participants in 2 patient groups

Threshold estimates
Experimental group
Description:
Descriptive case-scenarios
Treatment:
Other: descriptive case-scenarios
Alternative threshold estimates
Active Comparator group
Description:
Descriptive case-scenarios
Treatment:
Other: descriptive case-scenarios

Trial contacts and locations

1

Loading...

Central trial contact

Holger J Schunemann, MD, PhD; Gian Paolo Morgano, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems